Statin-Induced Insulin Resistance and Diabetes Risk

Clinical Evidence and Guidelines

Standard-dose statin therapy is associated with a 9% higher type 2 diabetes risk over four years, with greater risk seen with intensive statin therapy, according to the American College of Cardiology 1
The American Diabetes Association (2024) acknowledges that statin therapy may increase the risk of type 2 diabetes in people at high risk of developing diabetes 2
One cardiovascular event is prevented for each 100-150 people treated with a statin, while 500 people must be treated to cause one new case of type 2 diabetes, as reported by the American Heart Association 1

For patients requiring statin therapy who are at high risk of diabetes, the American Diabetes Association recommends regular monitoring of glucose status 2
The European Society of Cardiology notes that while statins may increase blood sugar and HbA1c levels, "the benefits of statins far outweigh the risks for the vast majority of patients" 4
For patients with prediabetes on statins, care goals should include weight loss or prevention of weight gain, minimizing the progression of hyperglycemia, and attention to cardiovascular risk factors, as suggested by the American Diabetes Association 3

The risk of statin-induced diabetes should not deter appropriate statin use for cardiovascular risk reduction, according to the American Diabetes Association 2
So far, similar diabetes risks have not been observed with non-statin lipid-lowering medications, except for niacin, as reported by the American College of Cardiology 1